Translation of Targeted Oncolytic Virotherapeutics from the Lab into the Clinic, and Back Again: A High-Value Iterative Loop

doi:doi:10.1038/mt.2008.70

Molecular Therapy (2008) 16 6, 1006–1008 doi:10.1038/mt.2008.70

Translation of Targeted Oncolytic Virotherapeutics from the Lab into the Clinic, and Back Again: A High-Value Iterative Loop

Ta-Chiang Liu¹, Tae-Ho Hwang^1,2, John C Bell^1,3 and David H Kirn^1,4

¹Jennerex Biotherapeutics, San Francisco, California, USA
²Pusan National University, Pusan, South Korea
³Ottawa Health Research Institute, Ottawa, Ontario, Canada
⁴Department of Clinical Pharmacology, University of Oxford Medical School, Oxford, UK

Correspondence: David H Kirn, Jennerex Biotherapeutics, One Market Street, Spear Tower, Suite 2260, San Francisco, California, USA. E-mail: dkirn@jennerex.com